Table 2.
Treatment cycles and the reasons for discontinuation.
| Arm A (N = 64) | Arm B (N = 64) | |
|---|---|---|
| Treatment courses, median (range) | 2 (1–28) | 4 (1–31) |
| Reasons for discontinuation | ||
| Disease progression, n (%) | 46 (71.9) | 33 (51.6) |
| Adverse events, n (%) | 6 (9.4) | 25 (39.1) |
| Participants' wish, n (%) | 7 (10.9) | 3 (4.7) |
| Death, n (%) | 0 | 1 (1.6) |
| Others, n (%) | 1 (1.6) | 0 |